nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—Tamoxifen—pancreatic cancer	0.474	1	CrCtD
Dextropropoxyphene—Toremifene—Tamoxifen—pancreatic cancer	0.0382	0.135	CrCrCtD
Dextropropoxyphene—Loperamide—Tamoxifen—pancreatic cancer	0.0254	0.0895	CrCrCtD
Dextropropoxyphene—Methadyl Acetate—Tamoxifen—pancreatic cancer	0.0254	0.0895	CrCrCtD
Dextropropoxyphene—Levomethadyl Acetate—Tamoxifen—pancreatic cancer	0.0254	0.0895	CrCrCtD
Dextropropoxyphene—Doxylamine—Tamoxifen—pancreatic cancer	0.0219	0.0774	CrCrCtD
Dextropropoxyphene—Phenoxybenzamine—Tamoxifen—pancreatic cancer	0.0208	0.0735	CrCrCtD
Dextropropoxyphene—Tripelennamine—Tamoxifen—pancreatic cancer	0.0198	0.07	CrCrCtD
Dextropropoxyphene—Dimetacrine—Tamoxifen—pancreatic cancer	0.0185	0.0654	CrCrCtD
Dextropropoxyphene—Methadone—Tamoxifen—pancreatic cancer	0.0174	0.0615	CrCrCtD
Dextropropoxyphene—CYP3A7—Tamoxifen—pancreatic cancer	0.0168	0.0927	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0168	0.0927	CbGbCtD
Dextropropoxyphene—Clofedanol—Tamoxifen—pancreatic cancer	0.0151	0.0531	CrCrCtD
Dextropropoxyphene—Orphenadrine—Tamoxifen—pancreatic cancer	0.0146	0.0514	CrCrCtD
Dextropropoxyphene—Benzphetamine—Tamoxifen—pancreatic cancer	0.0146	0.0514	CrCrCtD
Dextropropoxyphene—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.0135	0.0476	CrCrCtD
Dextropropoxyphene—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0129	0.0456	CrCrCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0129	0.0712	CbGbCtD
Dextropropoxyphene—CYP3A7—Irinotecan—pancreatic cancer	0.0129	0.0712	CbGbCtD
Dextropropoxyphene—CYP2C8—Tamoxifen—pancreatic cancer	0.0121	0.0669	CbGbCtD
Dextropropoxyphene—CYP2C8—Erlotinib—pancreatic cancer	0.0103	0.0569	CbGbCtD
Dextropropoxyphene—CYP3A7—Docetaxel—pancreatic cancer	0.00945	0.0522	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.00945	0.0522	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.00941	0.052	CbGbCtD
Dextropropoxyphene—CYP3A7—Sunitinib—pancreatic cancer	0.00941	0.052	CbGbCtD
Dextropropoxyphene—CYP2C8—Fluorouracil—pancreatic cancer	0.00893	0.0493	CbGbCtD
Dextropropoxyphene—CYP2C9—Tamoxifen—pancreatic cancer	0.00845	0.0467	CbGbCtD
Dextropropoxyphene—CYP2D6—Tamoxifen—pancreatic cancer	0.00773	0.0427	CbGbCtD
Dextropropoxyphene—CYP2D6—Erlotinib—pancreatic cancer	0.00657	0.0363	CbGbCtD
Dextropropoxyphene—CYP2C9—Fluorouracil—pancreatic cancer	0.00623	0.0344	CbGbCtD
Dextropropoxyphene—CYP3A4—Tamoxifen—pancreatic cancer	0.00491	0.0271	CbGbCtD
Dextropropoxyphene—CYP3A4—Erlotinib—pancreatic cancer	0.00418	0.0231	CbGbCtD
Dextropropoxyphene—CYP3A4—Irinotecan—pancreatic cancer	0.00377	0.0208	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—pancreatic cancer	0.00324	0.0179	CbGbCtD
Dextropropoxyphene—CYP3A4—Docetaxel—pancreatic cancer	0.00277	0.0153	CbGbCtD
Dextropropoxyphene—CYP3A4—Sunitinib—pancreatic cancer	0.00275	0.0152	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—pancreatic cancer	0.00206	0.0114	CbGbCtD
Dextropropoxyphene—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000135	0.00314	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Irinotecan—pancreatic cancer	0.000134	0.00314	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000134	0.00313	CcSEcCtD
Dextropropoxyphene—Insomnia—Erlotinib—pancreatic cancer	0.000134	0.00313	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Tamoxifen—pancreatic cancer	0.000134	0.00312	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Irinotecan—pancreatic cancer	0.000133	0.0031	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Erlotinib—pancreatic cancer	0.000132	0.00308	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Tamoxifen—pancreatic cancer	0.000132	0.00308	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Gemcitabine—pancreatic cancer	0.000131	0.00306	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000131	0.00305	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Erlotinib—pancreatic cancer	0.000131	0.00305	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Gemcitabine—pancreatic cancer	0.00013	0.00302	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000129	0.00302	CcSEcCtD
Dextropropoxyphene—Constipation—Tamoxifen—pancreatic cancer	0.000128	0.00299	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000128	0.00299	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000128	0.00298	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Fluorouracil—pancreatic cancer	0.000127	0.00297	CcSEcCtD
Dextropropoxyphene—Constipation—Erlotinib—pancreatic cancer	0.000127	0.00296	CcSEcCtD
Dextropropoxyphene—Shock—Sunitinib—pancreatic cancer	0.000126	0.00295	CcSEcCtD
Dextropropoxyphene—Coma—Epirubicin—pancreatic cancer	0.000126	0.00295	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Sunitinib—pancreatic cancer	0.000126	0.00294	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000123	0.00286	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000121	0.00283	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Tamoxifen—pancreatic cancer	0.000119	0.00276	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Erlotinib—pancreatic cancer	0.000117	0.00274	CcSEcCtD
Dextropropoxyphene—Vision blurred—Fluorouracil—pancreatic cancer	0.000117	0.00273	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—pancreatic cancer	0.000117	0.00273	CcSEcCtD
Dextropropoxyphene—Syncope—Irinotecan—pancreatic cancer	0.000116	0.00271	CcSEcCtD
Dextropropoxyphene—Insomnia—Sunitinib—pancreatic cancer	0.000116	0.00271	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000115	0.00268	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Sunitinib—pancreatic cancer	0.000114	0.00267	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Irinotecan—pancreatic cancer	0.000114	0.00266	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Sunitinib—pancreatic cancer	0.000113	0.00264	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000113	0.00264	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Docetaxel—pancreatic cancer	0.000112	0.00262	CcSEcCtD
Dextropropoxyphene—Jaundice—Docetaxel—pancreatic cancer	0.000112	0.00261	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000111	0.00259	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000111	0.00258	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00011	0.00258	CcSEcCtD
Dextropropoxyphene—Constipation—Sunitinib—pancreatic cancer	0.00011	0.00256	CcSEcCtD
Dextropropoxyphene—Discomfort—Irinotecan—pancreatic cancer	0.000109	0.00254	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000108	0.00253	CcSEcCtD
Dextropropoxyphene—Asthenia—Tamoxifen—pancreatic cancer	0.000108	0.00251	CcSEcCtD
Dextropropoxyphene—Convulsion—Fluorouracil—pancreatic cancer	0.000108	0.00251	CcSEcCtD
Dextropropoxyphene—Confusional state—Irinotecan—pancreatic cancer	0.000107	0.00249	CcSEcCtD
Dextropropoxyphene—Asthenia—Erlotinib—pancreatic cancer	0.000106	0.00248	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000106	0.00248	CcSEcCtD
Dextropropoxyphene—Discomfort—Gemcitabine—pancreatic cancer	0.000106	0.00248	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000105	0.00245	CcSEcCtD
Dextropropoxyphene—Discomfort—Fluorouracil—pancreatic cancer	0.000104	0.00244	CcSEcCtD
Dextropropoxyphene—Shock—Irinotecan—pancreatic cancer	0.000104	0.00243	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Irinotecan—pancreatic cancer	0.000104	0.00242	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Tamoxifen—pancreatic cancer	0.000103	0.00239	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000102	0.00239	CcSEcCtD
Dextropropoxyphene—Confusional state—Fluorouracil—pancreatic cancer	0.000102	0.00238	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Sunitinib—pancreatic cancer	0.000102	0.00237	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Erlotinib—pancreatic cancer	0.000102	0.00237	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000101	0.00236	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.0001	0.00234	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Fluorouracil—pancreatic cancer	9.94e-05	0.00232	CcSEcCtD
Dextropropoxyphene—Visual impairment—Docetaxel—pancreatic cancer	9.92e-05	0.00231	CcSEcCtD
Dextropropoxyphene—Dizziness—Tamoxifen—pancreatic cancer	9.92e-05	0.00231	CcSEcCtD
Dextropropoxyphene—Tachycardia—Fluorouracil—pancreatic cancer	9.89e-05	0.00231	CcSEcCtD
Dextropropoxyphene—Hypotension—Irinotecan—pancreatic cancer	9.88e-05	0.00231	CcSEcCtD
Dextropropoxyphene—Dizziness—Erlotinib—pancreatic cancer	9.81e-05	0.00229	CcSEcCtD
Dextropropoxyphene—Hypotension—Gemcitabine—pancreatic cancer	9.63e-05	0.00225	CcSEcCtD
Dextropropoxyphene—Eye disorder—Docetaxel—pancreatic cancer	9.62e-05	0.00224	CcSEcCtD
Dextropropoxyphene—Insomnia—Irinotecan—pancreatic cancer	9.57e-05	0.00223	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Docetaxel—pancreatic cancer	9.55e-05	0.00223	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Epirubicin—pancreatic cancer	9.54e-05	0.00223	CcSEcCtD
Dextropropoxyphene—Vomiting—Tamoxifen—pancreatic cancer	9.53e-05	0.00222	CcSEcCtD
Dextropropoxyphene—Hypotension—Fluorouracil—pancreatic cancer	9.47e-05	0.00221	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Sunitinib—pancreatic cancer	9.46e-05	0.00221	CcSEcCtD
Dextropropoxyphene—Rash—Tamoxifen—pancreatic cancer	9.45e-05	0.00221	CcSEcCtD
Dextropropoxyphene—Dermatitis—Tamoxifen—pancreatic cancer	9.45e-05	0.0022	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—pancreatic cancer	9.44e-05	0.0022	CcSEcCtD
Dextropropoxyphene—Vomiting—Erlotinib—pancreatic cancer	9.43e-05	0.0022	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Irinotecan—pancreatic cancer	9.43e-05	0.0022	CcSEcCtD
Dextropropoxyphene—Somnolence—Irinotecan—pancreatic cancer	9.4e-05	0.00219	CcSEcCtD
Dextropropoxyphene—Headache—Tamoxifen—pancreatic cancer	9.39e-05	0.00219	CcSEcCtD
Dextropropoxyphene—Rash—Erlotinib—pancreatic cancer	9.35e-05	0.00218	CcSEcCtD
Dextropropoxyphene—Dermatitis—Erlotinib—pancreatic cancer	9.35e-05	0.00218	CcSEcCtD
Dextropropoxyphene—Insomnia—Gemcitabine—pancreatic cancer	9.32e-05	0.00217	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Irinotecan—pancreatic cancer	9.31e-05	0.00217	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Docetaxel—pancreatic cancer	9.3e-05	0.00217	CcSEcCtD
Dextropropoxyphene—Headache—Erlotinib—pancreatic cancer	9.29e-05	0.00217	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	9.29e-05	0.00217	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Docetaxel—pancreatic cancer	9.28e-05	0.00216	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—pancreatic cancer	9.27e-05	0.00216	CcSEcCtD
Dextropropoxyphene—Asthenia—Sunitinib—pancreatic cancer	9.21e-05	0.00215	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Docetaxel—pancreatic cancer	9.19e-05	0.00214	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Gemcitabine—pancreatic cancer	9.19e-05	0.00214	CcSEcCtD
Dextropropoxyphene—Insomnia—Fluorouracil—pancreatic cancer	9.16e-05	0.00214	CcSEcCtD
Dextropropoxyphene—Somnolence—Gemcitabine—pancreatic cancer	9.16e-05	0.00214	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Irinotecan—pancreatic cancer	9.13e-05	0.00213	CcSEcCtD
Dextropropoxyphene—Constipation—Irinotecan—pancreatic cancer	9.05e-05	0.00211	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Fluorouracil—pancreatic cancer	9.03e-05	0.00211	CcSEcCtD
Dextropropoxyphene—Somnolence—Fluorouracil—pancreatic cancer	9.01e-05	0.0021	CcSEcCtD
Dextropropoxyphene—Malnutrition—Docetaxel—pancreatic cancer	8.96e-05	0.00209	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Fluorouracil—pancreatic cancer	8.92e-05	0.00208	CcSEcCtD
Dextropropoxyphene—Nausea—Tamoxifen—pancreatic cancer	8.91e-05	0.00208	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	8.9e-05	0.00207	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—pancreatic cancer	8.83e-05	0.00206	CcSEcCtD
Dextropropoxyphene—Constipation—Gemcitabine—pancreatic cancer	8.81e-05	0.00206	CcSEcCtD
Dextropropoxyphene—Nausea—Erlotinib—pancreatic cancer	8.81e-05	0.00206	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Sunitinib—pancreatic cancer	8.79e-05	0.00205	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	8.75e-05	0.00204	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—pancreatic cancer	8.73e-05	0.00204	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Irinotecan—pancreatic cancer	8.72e-05	0.00203	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Irinotecan—pancreatic cancer	8.65e-05	0.00202	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—pancreatic cancer	8.57e-05	0.002	CcSEcCtD
Dextropropoxyphene—Dizziness—Sunitinib—pancreatic cancer	8.49e-05	0.00198	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Gemcitabine—pancreatic cancer	8.49e-05	0.00198	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Irinotecan—pancreatic cancer	8.36e-05	0.00195	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Fluorouracil—pancreatic cancer	8.35e-05	0.00195	CcSEcCtD
Dextropropoxyphene—Vomiting—Sunitinib—pancreatic cancer	8.17e-05	0.0019	CcSEcCtD
Dextropropoxyphene—Rash—Sunitinib—pancreatic cancer	8.1e-05	0.00189	CcSEcCtD
Dextropropoxyphene—Dermatitis—Sunitinib—pancreatic cancer	8.09e-05	0.00189	CcSEcCtD
Dextropropoxyphene—Headache—Sunitinib—pancreatic cancer	8.05e-05	0.00188	CcSEcCtD
Dextropropoxyphene—Syncope—Docetaxel—pancreatic cancer	8.04e-05	0.00187	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Docetaxel—pancreatic cancer	7.88e-05	0.00184	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Irinotecan—pancreatic cancer	7.79e-05	0.00182	CcSEcCtD
Dextropropoxyphene—Convulsion—Docetaxel—pancreatic cancer	7.76e-05	0.00181	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—pancreatic cancer	7.73e-05	0.0018	CcSEcCtD
Dextropropoxyphene—Nausea—Sunitinib—pancreatic cancer	7.63e-05	0.00178	CcSEcCtD
Dextropropoxyphene—Asthenia—Irinotecan—pancreatic cancer	7.59e-05	0.00177	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—pancreatic cancer	7.54e-05	0.00176	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Fluorouracil—pancreatic cancer	7.46e-05	0.00174	CcSEcCtD
Dextropropoxyphene—Asthenia—Gemcitabine—pancreatic cancer	7.39e-05	0.00172	CcSEcCtD
Dextropropoxyphene—Confusional state—Docetaxel—pancreatic cancer	7.37e-05	0.00172	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—pancreatic cancer	7.31e-05	0.00171	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Irinotecan—pancreatic cancer	7.24e-05	0.00169	CcSEcCtD
Dextropropoxyphene—Shock—Docetaxel—pancreatic cancer	7.19e-05	0.00168	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Docetaxel—pancreatic cancer	7.17e-05	0.00167	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—pancreatic cancer	7.16e-05	0.00167	CcSEcCtD
Dextropropoxyphene—Tachycardia—Docetaxel—pancreatic cancer	7.14e-05	0.00166	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—pancreatic cancer	7.07e-05	0.00165	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Gemcitabine—pancreatic cancer	7.05e-05	0.00164	CcSEcCtD
Dextropropoxyphene—Dizziness—Irinotecan—pancreatic cancer	7e-05	0.00163	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—pancreatic cancer	6.97e-05	0.00163	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Fluorouracil—pancreatic cancer	6.93e-05	0.00162	CcSEcCtD
Dextropropoxyphene—Hypotension—Docetaxel—pancreatic cancer	6.83e-05	0.00159	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—pancreatic cancer	6.77e-05	0.00158	CcSEcCtD
Dextropropoxyphene—Vomiting—Irinotecan—pancreatic cancer	6.73e-05	0.00157	CcSEcCtD
Dextropropoxyphene—Dizziness—Fluorouracil—pancreatic cancer	6.7e-05	0.00156	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—pancreatic cancer	6.69e-05	0.00156	CcSEcCtD
Dextropropoxyphene—Rash—Irinotecan—pancreatic cancer	6.67e-05	0.00156	CcSEcCtD
Dextropropoxyphene—Dermatitis—Irinotecan—pancreatic cancer	6.66e-05	0.00155	CcSEcCtD
Dextropropoxyphene—Headache—Irinotecan—pancreatic cancer	6.63e-05	0.00155	CcSEcCtD
Dextropropoxyphene—Insomnia—Docetaxel—pancreatic cancer	6.61e-05	0.00154	CcSEcCtD
Dextropropoxyphene—Vomiting—Gemcitabine—pancreatic cancer	6.55e-05	0.00153	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—pancreatic cancer	6.54e-05	0.00153	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Docetaxel—pancreatic cancer	6.52e-05	0.00152	CcSEcCtD
Dextropropoxyphene—Somnolence—Docetaxel—pancreatic cancer	6.5e-05	0.00152	CcSEcCtD
Dextropropoxyphene—Rash—Gemcitabine—pancreatic cancer	6.5e-05	0.00152	CcSEcCtD
Dextropropoxyphene—Dermatitis—Gemcitabine—pancreatic cancer	6.49e-05	0.00151	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—pancreatic cancer	6.49e-05	0.00151	CcSEcCtD
Dextropropoxyphene—Headache—Gemcitabine—pancreatic cancer	6.46e-05	0.00151	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—pancreatic cancer	6.44e-05	0.0015	CcSEcCtD
Dextropropoxyphene—Vomiting—Fluorouracil—pancreatic cancer	6.44e-05	0.0015	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Docetaxel—pancreatic cancer	6.44e-05	0.0015	CcSEcCtD
Dextropropoxyphene—Rash—Fluorouracil—pancreatic cancer	6.39e-05	0.00149	CcSEcCtD
Dextropropoxyphene—Dermatitis—Fluorouracil—pancreatic cancer	6.38e-05	0.00149	CcSEcCtD
Dextropropoxyphene—Headache—Fluorouracil—pancreatic cancer	6.35e-05	0.00148	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Docetaxel—pancreatic cancer	6.31e-05	0.00147	CcSEcCtD
Dextropropoxyphene—Nausea—Irinotecan—pancreatic cancer	6.28e-05	0.00147	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—pancreatic cancer	6.27e-05	0.00146	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—pancreatic cancer	6.26e-05	0.00146	CcSEcCtD
Dextropropoxyphene—Constipation—Docetaxel—pancreatic cancer	6.25e-05	0.00146	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—pancreatic cancer	6.2e-05	0.00145	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—pancreatic cancer	6.19e-05	0.00144	CcSEcCtD
Dextropropoxyphene—Nausea—Gemcitabine—pancreatic cancer	6.12e-05	0.00143	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—pancreatic cancer	6.04e-05	0.00141	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Docetaxel—pancreatic cancer	6.03e-05	0.00141	CcSEcCtD
Dextropropoxyphene—Nausea—Fluorouracil—pancreatic cancer	6.02e-05	0.0014	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—pancreatic cancer	6e-05	0.0014	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Docetaxel—pancreatic cancer	5.98e-05	0.00139	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—pancreatic cancer	5.96e-05	0.00139	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—pancreatic cancer	5.8e-05	0.00135	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—pancreatic cancer	5.79e-05	0.00135	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Docetaxel—pancreatic cancer	5.78e-05	0.00135	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—pancreatic cancer	5.74e-05	0.00134	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—pancreatic cancer	5.7e-05	0.00133	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—pancreatic cancer	5.59e-05	0.0013	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—pancreatic cancer	5.55e-05	0.0013	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—pancreatic cancer	5.42e-05	0.00126	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Docetaxel—pancreatic cancer	5.39e-05	0.00126	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—pancreatic cancer	5.31e-05	0.00124	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—pancreatic cancer	5.27e-05	0.00123	CcSEcCtD
Dextropropoxyphene—Asthenia—Docetaxel—pancreatic cancer	5.25e-05	0.00122	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—pancreatic cancer	5.24e-05	0.00122	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—pancreatic cancer	5.14e-05	0.0012	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—pancreatic cancer	5.08e-05	0.00119	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—pancreatic cancer	5.01e-05	0.00117	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Docetaxel—pancreatic cancer	5e-05	0.00117	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—pancreatic cancer	4.97e-05	0.00116	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—pancreatic cancer	4.91e-05	0.00115	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—pancreatic cancer	4.85e-05	0.00113	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—pancreatic cancer	4.84e-05	0.00113	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—pancreatic cancer	4.84e-05	0.00113	CcSEcCtD
Dextropropoxyphene—Dizziness—Docetaxel—pancreatic cancer	4.84e-05	0.00113	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—pancreatic cancer	4.81e-05	0.00112	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—pancreatic cancer	4.7e-05	0.0011	CcSEcCtD
Dextropropoxyphene—Vomiting—Docetaxel—pancreatic cancer	4.65e-05	0.00108	CcSEcCtD
Dextropropoxyphene—Rash—Docetaxel—pancreatic cancer	4.61e-05	0.00108	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—pancreatic cancer	4.61e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Dermatitis—Docetaxel—pancreatic cancer	4.61e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—pancreatic cancer	4.6e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Headache—Docetaxel—pancreatic cancer	4.58e-05	0.00107	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—pancreatic cancer	4.49e-05	0.00105	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—pancreatic cancer	4.48e-05	0.00104	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—pancreatic cancer	4.46e-05	0.00104	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—pancreatic cancer	4.45e-05	0.00104	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—pancreatic cancer	4.4e-05	0.00103	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—pancreatic cancer	4.38e-05	0.00102	CcSEcCtD
Dextropropoxyphene—Nausea—Docetaxel—pancreatic cancer	4.34e-05	0.00101	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—pancreatic cancer	4.34e-05	0.00101	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—pancreatic cancer	4.26e-05	0.000995	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.26e-05	0.000993	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—pancreatic cancer	4.22e-05	0.000984	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—pancreatic cancer	4.13e-05	0.000963	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—pancreatic cancer	4.07e-05	0.000949	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—pancreatic cancer	4.06e-05	0.000948	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—pancreatic cancer	4.06e-05	0.000946	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.03e-05	0.000941	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—pancreatic cancer	4.02e-05	0.000937	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.94e-05	0.000919	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—pancreatic cancer	3.9e-05	0.00091	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—pancreatic cancer	3.9e-05	0.000909	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—pancreatic cancer	3.76e-05	0.000877	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.73e-05	0.00087	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—pancreatic cancer	3.63e-05	0.000848	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—pancreatic cancer	3.61e-05	0.000841	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—pancreatic cancer	3.54e-05	0.000825	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Epirubicin—pancreatic cancer	3.37e-05	0.000787	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—pancreatic cancer	3.36e-05	0.000784	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—pancreatic cancer	3.27e-05	0.000764	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—pancreatic cancer	3.26e-05	0.000761	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—pancreatic cancer	3.14e-05	0.000731	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—pancreatic cancer	3.12e-05	0.000728	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—pancreatic cancer	3.11e-05	0.000725	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—pancreatic cancer	3.11e-05	0.000725	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—pancreatic cancer	3.09e-05	0.000721	CcSEcCtD
Dextropropoxyphene—Dizziness—Doxorubicin—pancreatic cancer	3.02e-05	0.000704	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—pancreatic cancer	2.93e-05	0.000683	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—pancreatic cancer	2.9e-05	0.000677	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—pancreatic cancer	2.88e-05	0.000671	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—pancreatic cancer	2.87e-05	0.000671	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—pancreatic cancer	2.86e-05	0.000667	CcSEcCtD
Dextropropoxyphene—Nausea—Doxorubicin—pancreatic cancer	2.71e-05	0.000632	CcSEcCtD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	7.46e-06	0.000409	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	7.45e-06	0.000408	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	7.25e-06	0.000397	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	7.23e-06	0.000396	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GCG—pancreatic cancer	7.19e-06	0.000394	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TYMP—pancreatic cancer	7.01e-06	0.000384	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	7e-06	0.000384	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.96e-06	0.000381	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	6.86e-06	0.000376	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SST—pancreatic cancer	6.82e-06	0.000374	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STK11—pancreatic cancer	6.76e-06	0.000371	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	6.76e-06	0.00037	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.73e-06	0.000369	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	6.68e-06	0.000366	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	6.67e-06	0.000366	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	6.65e-06	0.000364	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HES1—pancreatic cancer	6.6e-06	0.000362	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ARG2—pancreatic cancer	6.58e-06	0.000361	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ARG2—pancreatic cancer	6.52e-06	0.000358	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CD44—pancreatic cancer	6.52e-06	0.000358	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	6.35e-06	0.000348	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	6.32e-06	0.000346	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	6.29e-06	0.000345	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GCG—pancreatic cancer	6.25e-06	0.000343	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	6.11e-06	0.000335	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.1e-06	0.000334	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GCG—pancreatic cancer	6.08e-06	0.000333	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	6.07e-06	0.000333	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	5.92e-06	0.000325	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.91e-06	0.000324	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—STK11—pancreatic cancer	5.88e-06	0.000322	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	5.86e-06	0.000321	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	5.8e-06	0.000318	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HES1—pancreatic cancer	5.78e-06	0.000317	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.78e-06	0.000317	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TERT—pancreatic cancer	5.78e-06	0.000317	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TYMP—pancreatic cancer	5.75e-06	0.000315	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STK11—pancreatic cancer	5.72e-06	0.000313	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TYMP—pancreatic cancer	5.7e-06	0.000313	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GLP1R—pancreatic cancer	5.65e-06	0.00031	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—DPYD—pancreatic cancer	5.56e-06	0.000305	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	5.54e-06	0.000304	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	5.53e-06	0.000303	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	5.51e-06	0.000302	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—APOE—pancreatic cancer	5.4e-06	0.000296	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	5.37e-06	0.000294	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	5.32e-06	0.000292	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KDR—pancreatic cancer	5.29e-06	0.00029	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	5.27e-06	0.000289	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.22e-06	0.000286	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.15e-06	0.000283	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TERT—pancreatic cancer	5.07e-06	0.000278	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—TYMS—pancreatic cancer	5.06e-06	0.000277	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.04e-06	0.000276	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	5.03e-06	0.000276	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	5.01e-06	0.000274	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	4.98e-06	0.000273	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.96e-06	0.000272	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	4.95e-06	0.000272	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HES1—pancreatic cancer	4.89e-06	0.000268	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	4.87e-06	0.000267	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	4.87e-06	0.000267	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	4.85e-06	0.000266	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	4.83e-06	0.000265	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGF—pancreatic cancer	4.81e-06	0.000264	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—APOE—pancreatic cancer	4.73e-06	0.000259	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.71e-06	0.000258	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	4.68e-06	0.000257	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GLP1R—pancreatic cancer	4.64e-06	0.000254	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KDR—pancreatic cancer	4.64e-06	0.000254	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GLP1R—pancreatic cancer	4.6e-06	0.000252	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.59e-06	0.000252	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—DPYD—pancreatic cancer	4.56e-06	0.00025	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—DPYD—pancreatic cancer	4.52e-06	0.000248	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	4.5e-06	0.000247	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	4.44e-06	0.000243	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	4.41e-06	0.000242	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	4.37e-06	0.000239	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	4.33e-06	0.000237	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.3e-06	0.000236	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	4.29e-06	0.000235	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TERT—pancreatic cancer	4.28e-06	0.000235	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	4.28e-06	0.000235	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	4.27e-06	0.000234	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	4.27e-06	0.000234	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.25e-06	0.000233	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.24e-06	0.000232	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGF—pancreatic cancer	4.22e-06	0.000231	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	4.19e-06	0.00023	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—APOE—pancreatic cancer	4.11e-06	0.000226	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.1e-06	0.000225	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	4.1e-06	0.000225	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	4.09e-06	0.000224	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CD44—pancreatic cancer	4.08e-06	0.000224	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—APOE—pancreatic cancer	4e-06	0.000219	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4e-06	0.000219	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.96e-06	0.000217	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KDR—pancreatic cancer	3.92e-06	0.000215	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GCG—pancreatic cancer	3.91e-06	0.000215	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	3.89e-06	0.000213	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.85e-06	0.000211	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.76e-06	0.000206	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	3.75e-06	0.000206	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.73e-06	0.000205	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	3.73e-06	0.000205	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	3.73e-06	0.000204	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.72e-06	0.000204	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	3.71e-06	0.000204	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	3.69e-06	0.000202	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—STK11—pancreatic cancer	3.68e-06	0.000202	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	3.67e-06	0.000201	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	3.61e-06	0.000198	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	3.61e-06	0.000198	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	3.59e-06	0.000197	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PPARG—pancreatic cancer	3.58e-06	0.000196	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGF—pancreatic cancer	3.57e-06	0.000196	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	3.56e-06	0.000195	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	3.46e-06	0.00019	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.46e-06	0.000189	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	3.43e-06	0.000188	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.38e-06	0.000185	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CD44—pancreatic cancer	3.35e-06	0.000184	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	3.34e-06	0.000183	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CD44—pancreatic cancer	3.32e-06	0.000182	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	3.31e-06	0.000181	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	3.29e-06	0.00018	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	3.27e-06	0.000179	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	3.26e-06	0.000179	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.25e-06	0.000178	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	3.24e-06	0.000178	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.22e-06	0.000177	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	3.22e-06	0.000177	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GCG—pancreatic cancer	3.21e-06	0.000176	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GCG—pancreatic cancer	3.19e-06	0.000175	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	3.17e-06	0.000174	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TYMS—pancreatic cancer	3.17e-06	0.000174	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	3.15e-06	0.000172	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	3.14e-06	0.000172	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.14e-06	0.000172	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	3.12e-06	0.000171	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	3.11e-06	0.00017	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	3.04e-06	0.000167	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.03e-06	0.000166	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—STK11—pancreatic cancer	3.02e-06	0.000166	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	3.01e-06	0.000165	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—STK11—pancreatic cancer	3e-06	0.000164	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SRC—pancreatic cancer	2.99e-06	0.000164	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.98e-06	0.000164	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	2.93e-06	0.000161	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	2.91e-06	0.00016	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	2.9e-06	0.000159	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	2.88e-06	0.000158	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	2.88e-06	0.000158	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.85e-06	0.000156	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	2.84e-06	0.000156	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	2.84e-06	0.000156	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.83e-06	0.000155	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	2.83e-06	0.000155	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—pancreatic cancer	2.82e-06	0.000155	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.81e-06	0.000154	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	2.77e-06	0.000152	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	2.76e-06	0.000151	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MYC—pancreatic cancer	2.68e-06	0.000147	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	2.67e-06	0.000147	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	2.66e-06	0.000146	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	2.64e-06	0.000145	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SRC—pancreatic cancer	2.62e-06	0.000144	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	2.62e-06	0.000144	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.6e-06	0.000143	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TYMS—pancreatic cancer	2.58e-06	0.000141	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—APOE—pancreatic cancer	2.58e-06	0.000141	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	2.57e-06	0.000141	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	2.55e-06	0.00014	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	2.54e-06	0.000139	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	2.53e-06	0.000139	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	2.52e-06	0.000138	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	2.48e-06	0.000136	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	2.48e-06	0.000136	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTEN—pancreatic cancer	2.46e-06	0.000135	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	2.45e-06	0.000134	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.44e-06	0.000134	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	2.4e-06	0.000132	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	2.39e-06	0.000131	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MYC—pancreatic cancer	2.35e-06	0.000129	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	2.34e-06	0.000129	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	2.33e-06	0.000128	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	2.32e-06	0.000127	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	2.3e-06	0.000126	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	2.27e-06	0.000125	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARG—pancreatic cancer	2.24e-06	0.000123	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SRC—pancreatic cancer	2.22e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—pancreatic cancer	2.2e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CD44—pancreatic cancer	2.19e-06	0.00012	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	2.17e-06	0.000119	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	2.16e-06	0.000118	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	2.14e-06	0.000117	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	2.13e-06	0.000117	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—APOE—pancreatic cancer	2.11e-06	0.000116	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	2.1e-06	0.000115	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GCG—pancreatic cancer	2.1e-06	0.000115	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—APOE—pancreatic cancer	2.1e-06	0.000115	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.04e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	1.99e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MYC—pancreatic cancer	1.99e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.98e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.98e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—STK11—pancreatic cancer	1.98e-06	0.000108	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	1.94e-06	0.000106	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—pancreatic cancer	1.93e-06	0.000106	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.91e-06	0.000105	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.89e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	1.86e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	1.85e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.84e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	1.83e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.83e-06	0.0001	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.78e-06	9.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.76e-06	9.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	1.73e-06	9.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.7e-06	9.32e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.69e-06	9.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.68e-06	9.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.66e-06	9.12e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—pancreatic cancer	1.63e-06	8.94e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	1.63e-06	8.93e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	1.56e-06	8.55e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTEN—pancreatic cancer	1.54e-06	8.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.46e-06	8.02e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	1.45e-06	7.95e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.45e-06	7.94e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—pancreatic cancer	1.44e-06	7.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AKT1—pancreatic cancer	1.42e-06	7.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—APOE—pancreatic cancer	1.38e-06	7.58e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	1.38e-06	7.55e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.26e-06	6.93e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.25e-06	6.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.25e-06	6.84e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.2e-06	6.6e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.1e-06	6.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.09e-06	5.95e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	9.56e-07	5.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—pancreatic cancer	9.47e-07	5.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	8.91e-07	4.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AKT1—pancreatic cancer	8.87e-07	4.86e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	8.83e-07	4.84e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTEN—pancreatic cancer	8.26e-07	4.53e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AKT1—pancreatic cancer	7.28e-07	3.99e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AKT1—pancreatic cancer	7.22e-07	3.96e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.83e-07	3.19e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.76e-07	2.61e-05	CbGpPWpGaD
